ACTR2 and central nervous system cancer: It has also been reported that high expression of Arp2/3 positively correlates with the malignancy of glioma specimens and that Arp2/3 system deregulation promotes cancer progression and directly impacts patient survival (Liu et al., 2013; Molinie and Gautreau, 2018).